Not exact matches
«The trial is important for
gene research and may be a proof of principle that targeting the most common
mutation in cystic
fibrosis is an effective approach for treatment of most patients,» Gentzsch said.
McCauley's interest is cystic
fibrosis, a disease caused by
mutations in a single
gene, CFTR.
Cystic
fibrosis is a rare inherited disease caused by
mutations in a single
gene called cystic
fibrosis transmembrane conductance regulator (CFTR) and affects 1 in every 2500 newborns in the UK and over 90000 people worldwide.
Yale researchers successfully corrected the most common
mutation in the
gene that causes cystic
fibrosis, a lethal genetic disorder.
It is most commonly caused by a
mutation in the cystic
fibrosis gene known as F508del.
«
Gene editing used to correct
mutation in cystic
fibrosis.»
Researchers at UT Southwestern Medical Center have identified
mutations in two
genes that cause a fatal lung scarring disease known as familial pulmonary
fibrosis.
Cystic
fibrosis is a hereditary disease caused by
mutations in a single
gene called CFTR.
Most
mutations are neutral, having no effect on
gene function; others are harmful, such as the ones that cause inherited diseases like cystic
fibrosis.
And the technique will benefit not just cancer research but research into every disease driven by
gene mutations, from cystic
fibrosis to Alzheimer's disease — ultimately enabling customized treatments for patients in a way never before possible.
Ivacaftor is the first drug to treat the underlying causes of cystic
fibrosis rather than just its symptoms and is currently approved for patients with the «celtic
gene»
mutation carried by about four per cent of all patients and 10 - 15 per cent of patients in Ireland.
While we had previously found an effective treatment for those with the «celtic
gene» this new combination treatment has the potential to help roughly half of those with cystic
fibrosis, those who have two copies the F508DEL
mutation.
Last month, researchers from the Netherland's Utrecht institute reported in Cell Stem Cell that CRISPR corrected the
gene mutation responsible for cystic
fibrosis in stem cells developed from two children with the life - threatening disease.
Overlap — Finally, successful drug targets significantly overlap with disease
genes — those in which a
mutation can cause a specific disease, such as cystic
fibrosis — and with essential
genes, that are required for normal development.
Take cystic
fibrosis, a genetic disease that creates a life - threatening accumulation of mucus in the lungs and is known to result from a single
mutation in a single
gene.
«Now we are closer to understanding why patients with the exact same genetic
mutation in the cystic
fibrosis gene have such widely varying manifestations of lung disease, and closer to finding new therapies.»
Though every CF patient carries
mutations in both copies of the same
gene — coding for a protein called cystic
fibrosis transmembrane conductance regulator or CFTR — symptoms can vary widely from patient to patient.